Injection site reactions due to the use of biologics in patients with psoriasis: A retrospective study

JAAD Int. 2022 Oct 30:10:36-38. doi: 10.1016/j.jdin.2022.10.006. eCollection 2023 Mar.

¹ Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

No abstract available

Keywords: adalimumab; biologics; guselkumab; injection site reactions; ixekizumab; psoriasis; risankizumab; secukinumab; ustekinumab.